The art of bone regeneration
There are no safety concerns or natural constraints to the availability of synthetic bone grafts and developments have greatly improved their efficacy.
Synthetic bone grafts have proven to be an excellent alternative to human bone, especially when used in conjunction with bone marrow or proline-rich proteins (PRPs), which adds osteoinductive properties to the graft.
Leader Biomedical’s Ossfinity® combines OssGro® granules with an absorbable hydrogel to create a putty. Our OssGro® line of synthetic bone grafts are produced with MBCP™ Technology, a proprietary method for producing high quality synthetic bone grafts composed of 60% HA and 40% βTCP. Synthetic bone grafts produced with MBCP™ Technology exhibit: